Author Details

Tyutyunnik, Victor L.

Issue Section Title File
No 10 (2014) Articles Prediction of fetal growth retardation in pregnant women with undifferentiated connective tissue dysplasia
No 3 (2015) Articles Placental apoptosis and antioxidant defense enzyme gene expression in preeclampsia
No 4 (2015) Articles DIAGNOSTIC ROLE OF THE CLINICAL AND MOLECULAR GENETIC PREDICTORS OF INTRAUTERINE INFECTION
No 1 (2015) Articles Specific features of uterine scar formation after cesarean section in undifferentiated connective tissue dysplasia
No 1 (2015) Articles Calcium supplements in the prevention of pregnancy complications
No 6 (2015) Articles CURRENT APPROACHES TO TREATING PAPILLOMAVIRUS INFECTION
No 12 (2015) Articles PATHOGENETIC ASPECTS OF PREECLAMPSIA
No 12 (2015) Articles CURRENT PRINCIPLES OF THERAPY FOR PAPILLOMAVIRUS INFECTION
No 2 (2016) Articles Significance of detoxification system gene polymorphisms in preeclampsia
No 4 (2016) Articles Medically induced abortion at 12 to 22 weeks gestation: Indications, methods, and results
No 5 (2016) Articles PRO- AND ANTIOXIDANT SYSTEM IN PRETERM BIRTH
No 1 (2016) Articles SPECIFIC FEATURES OF ANTIOXIDANT DEFENSE IN THE MOTHER-PLACENTA-FETUS SYSTEM IN INTRAUTERINE INFECTION
No 3 (2016) Articles AUTOANTIBODIES AGAINST ENDOTHELIAL ANTIGENS IN PREECLAMPSIA
No 6 (2016) Articles Clinical and anamnestic risk factors for preeclampsia in pregnant women
No 5 (2016) Articles OXIDATIVE STRESS IN PREECLAMPSIA AND IN NORMAL PREGNANCY
No 12 (2016) Articles QUANTIFICATION OF PLASMA MICRORNA EXPRESSION IN PREGNANT WOMEN WITH PREECLAMPSIA
No 4 (2017) Articles Diagnostic significance of malondialdehyde level and catalase activity evaluation in women with preterm labor
No 9 (2017) Articles Pathogenetic mechanisms of placental insufficiency and preeclampsia
No 10 (2017) Articles Pregnancy management complicated by intrauterine growth restriction
No 10 (2017) Articles Patient-centered care: The vector of development of obstetric hospital
No 4 (2018) Articles Integrated approach to preeclampsia prediction based on molecular genetics and clinical factors
No 3 (2018) Articles The role of the soluble fms-like tyrosin kinase-1 / the placental growth factor ratio in the diagnostics of preeclampsia in physiological pregnancy and pregnancy after IVF
No 6 (2018) Articles The role of E-kadherin in the formation of intrauterine growth restriction
No 11 (2018) Articles Diagnostic value of preactivated neutrophils in preeclampsia
No 12 (2018) Articles The role of methylentetrahydrofolate reductase (MTHFR) gene polymorphism in intrauterine growth restriction development
No 11 (2018) Articles Predicting impairment of pre-lactation transformation and preventing lactogenesis failure in metabolic syndrome
No 8 (2018) Articles BACTERIAL VAGINOSIS AND ANTIMICROBIAL ACTIVITY DURING PREGNANCY
No 8 (2018) Articles CORRECTION OF IRON-DEFICIENCY ANEMIA IN PREGNANT WOMEN
No 1 (2019) Articles Predicting preterm labor by combined testing of cytokines and cell-free DNA
No 4 (2019) Articles The role of preeclampsia in pregnancy outcomes: the view of a neonatologist
No 5 (2019) Articles The features and efficiency of therapy for uncomplicated cystitis in pregnant women and puerperas
No 5 (2019) Articles Late pregnancy termination by a medical technique in combination with cervical osmotic dilators
No 7 (2019) Articles Prediction of pre-eclampsia on the couts of CD-16 negative monocytes
No 12 (2019) Articles Gene methylation in the placenta of fetuses with fetal growth restriction
No 12 (2019) Articles Metabolomic profile in pregnant women with fetal growth restriction
No 8 (2019) Articles DIAGNOSTIC SIGNIFICANCE OF DETERMINING THE LEVEL OF EXTRACELLULAR FETAL DNA IN PREGNANT WOMEN WITH PREECLAMPSIA AND FETAL GROWTH RESTRICTION
No 6 (2020) Articles Plasma levels of soluble E-cadherin and the keratinocytes growth factor in intrauterine growth restriction
No 7 (2020) Articles Methylation of the TLR2 and IGF2/H19 ICR genes in the placenta and blood plasma in preeclampsia
No 6 (2020) Articles Iron deficiency states during pregnancy: prevention and treatment
No 3 (2021) Articles Possibilities of predicting preterm birth using mitochondrial DNA and VDAC1 protein
No 6 (2021) Articles Predictive value of testing for maternal plasma cell-free fetal DNA in fetal growth restriction
No 10 (2021) Articles Features of changes in the monocyte-macrophage cells in the placenta during preeclampsia
No 9 (2021) Articles Association between the level of specific urinary SERPINA1 protein in pregnant women and the severity of preeclampsia and perinatal outcomes
No 8 (2022) Articles Fetal growth retardation in the context of fetal programming
No 8 (2022) Articles A comprehensive approach to treating chronic recurrent uncomplicated cystitis during pregnancy
No 5 (2022) Articles Favorable maternal and perinatal outcomes of pregnancy in a COVID-19 patient with total lung damage
No 12 (2022) Articles Epigenetic aspects of the pathogenesis of preeclampsia
No 11 (2022) Articles Features of neurogenesis in fetal growth restriction
No 11 (2022) Articles Asymptomatic bacteriuria in pregnancy: a modern approach to therapy
No 1 (2022) Articles Role of insulin resistance in the mechanisms of adaptation and development of female reproductive system disease
No 1 (2022) Articles Prooxidant and antioxidant content in capillary blood in preterm birth
No 4 (2022) Articles Preeclampsia as a separate gestational clinical and pathogenetic form of insulin resistance syndrome
No 2 (2022) Articles Role of insulin resistance in the mechanisms of adaptation and development of disease in postpartum and early neonatal periods
No 3 (2023) Clinical Notes Intra-abdominal hemorrhage in a pregnant woman as a manifestation of endometrioid disease
No 9 (2020) Articles Earlyand late-onset fetal growth restriction: differential diagnosis based on proand antioxidant system markers
No 10 (2016) Articles LOCAL FACTORS OF INNATE IMMUNITY IN THE PREDICTION OF PRETERM BIRTH
No 2 (2023) Original Articles Association between new coronavirus infection and fetal growth restriction
No 5 (2023) Reviews Role of mitochondrial dysfunction in the pathogenesis of premature birth
No 5 (2023) Original Articles Phenotypic profile of peripheral blood mononuclear cells in preeclampsia
No 7 (2023) Exchange of Experience Complex therapy of bacterial vaginosis during pregnancy
No 8 (2023) Original Articles Diagnostic significance of determining the expression of energy metabolism genes in fetal growth retardation
No 9 (2023) Original Articles Clinical and pathogenetic rationale for two-stage prevention of preeclampsia in high-risk women using an insulin sensitizer for preconception preparation
No 9 (2023) Original Articles Clinical and anamnestic factors in the prediction and diagnosis of fetal growth restriction
No 10 (2023) Reviews Controversial issues of antenatal glucocorticoid use in fetal growth retardation
No 10 (2023) Reviews Modern concepts on the etiology and pathogenesis of premature rupture of membranes
No 11 (2023) Reviews Molecular genetic markers in the pathogenesis of fetal growth retardation
No 11 (2023) Exchange of Experience Complex therapy of recurrent vulvovaginal candidiasis in pregnancy
No 3 (2024) Guidelines for the Practitioner Algorithm for diagnosis and treatment of gastroesophageal reflux disease in pregnant women
No 4 (2024) Reviews The concept of epigenetic modifications in fetal metabolic programming
No 4 (2024) Original Articles Diagnostic significance of proteome analysis of maternal plasma in fetal growth restriction
No 4 (2024) Original Articles Rationale for preoperative treatment of advanced-stage endometrial ovarian cysts in infertile women
No 4 (2024) Guidelines for the Practitioner Modern concepts in the treatment of urogenital chlamydia trachomatis infection during pregnancy

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies